Trypobase is an acronym and stands for “Nucleobase derivatives as drugs against trypanosomal diseases”. Trypobase is a collaborative research project which is funded under the European Community´s 7th Framework Programme. This project directly addresses research in neglected infectious diseases and the development of new tools to control infections due to parasites of the Trypanosomatidae family.
Other overall objectives covered include translational research in major infectious diseases and innovative therapeutic approaches and interventions.
The project will approach initially all three diseases (Trypanosomiasis, Chagas disease, Leishmaniasis) and the main objective is to develop new interventions by means of the development of new drugs or drug combinations.
Trypobase is running from January 2009 until June 2012, and represents a scientific collaboration between 7 partners from Asia, Europe and South America.